Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro
- 25 February 2020
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 875, 173031
- https://doi.org/10.1016/j.ejphar.2020.173031
Abstract
No abstract availableKeywords
Funding Information
- Macao Science and Technology Development Fund (071/2017/A2)
- China Postdoctoral Science Foundation (2017M622811)
- Natural Science Foundation of Guangdong Province, China (2018A030310226)
- Educational Commission of Guangdong Province, China (2017KQNCX084)
- University of Macau (CPG2020-00016-IMCS)
This publication has 46 references indexed in Scilit:
- Cardiovascular Toxicities of Cancer ChemotherapySeminars in Oncology, 2013
- Impact of Temozolomide on Immune Response during Malignant Glioma ChemotherapyJournal of Immunology Research, 2012
- Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 ExpressionPLOS ONE, 2012
- Anti-cancer natural products isolated from chinese medicinal herbsChinese Medicine, 2011
- The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal ToxicityScience Translational Medicine, 2010
- Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiationFitoterapia, 2010
- Rhizoma coptidisInhibits LPS-Induced MCP-1/CCL2 Production in Murine Macrophages via an AP-1 and NFB-Dependent PathwayMediators of Inflammation, 2010
- Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia rutaecarpaMolecules, 2009
- Nrf2 Activation Involves an Oxidative-Stress Independent Pathway in Tetrafluoroethylcysteine-Induced CytotoxicityToxicological Sciences, 2005
- Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell SurvivalMolecular and Cellular Biology, 2003